Global Ophthalmic Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Ophthalmic Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Ophthalmic Biologics industry chain, the market status of Age-related Macular Degeneration Treatment (Ranibizumab, Bevacizumab), Diabetic Retinopathy Treatment (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ophthalmic Biologics.
Regionally, the report analyzes the Ophthalmic Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ophthalmic Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ophthalmic Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ophthalmic Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ophthalmic Biologics market.
Regional Analysis: The report involves examining the Ophthalmic Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ophthalmic Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ophthalmic Biologics:
Company Analysis: Report covers individual Ophthalmic Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ophthalmic Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration Treatment, Diabetic Retinopathy Treatment).
Technology Analysis: Report covers specific technologies relevant to Ophthalmic Biologics. It assesses the current state, advancements, and potential future developments in Ophthalmic Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ophthalmic Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ophthalmic Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Ophthalmic Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ophthalmic Biologics, with price, sales, revenue and global market share of Ophthalmic Biologics from 2019 to 2024.
Chapter 3, the Ophthalmic Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ophthalmic Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Biologics.
Chapter 14 and 15, to describe Ophthalmic Biologics sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Ophthalmic Biologics industry chain, the market status of Age-related Macular Degeneration Treatment (Ranibizumab, Bevacizumab), Diabetic Retinopathy Treatment (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ophthalmic Biologics.
Regionally, the report analyzes the Ophthalmic Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ophthalmic Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ophthalmic Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ophthalmic Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ophthalmic Biologics market.
Regional Analysis: The report involves examining the Ophthalmic Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ophthalmic Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ophthalmic Biologics:
Company Analysis: Report covers individual Ophthalmic Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ophthalmic Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration Treatment, Diabetic Retinopathy Treatment).
Technology Analysis: Report covers specific technologies relevant to Ophthalmic Biologics. It assesses the current state, advancements, and potential future developments in Ophthalmic Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ophthalmic Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ophthalmic Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Age-related Macular Degeneration Treatment
- Diabetic Retinopathy Treatment
- Inhibit Abnormal Angiogenesis
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Ophthalmic Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ophthalmic Biologics, with price, sales, revenue and global market share of Ophthalmic Biologics from 2019 to 2024.
Chapter 3, the Ophthalmic Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ophthalmic Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Biologics.
Chapter 14 and 15, to describe Ophthalmic Biologics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Ophthalmic Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ophthalmic Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Ophthalmic Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration Treatment
1.4.3 Diabetic Retinopathy Treatment
1.4.4 Inhibit Abnormal Angiogenesis
1.5 Global Ophthalmic Biologics Market Size & Forecast
1.5.1 Global Ophthalmic Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Ophthalmic Biologics Sales Quantity (2019-2030)
1.5.3 Global Ophthalmic Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Ophthalmic Biologics Product and Services
2.1.4 Sanofi Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Ophthalmic Biologics Product and Services
2.2.4 Novartis Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Ophthalmic Biologics Product and Services
2.3.4 Bayer Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Ophthalmic Biologics Product and Services
2.4.4 Genentech Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
2.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Ophthalmic Biologics Product and Services
2.7.4 Iveric Bio
Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Ophthalmic Biologics Product and Services
2.8.4 Regeneron Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Qilu Pharmaceutical Co.,Ltd.
2.9.1 Qilu Pharmaceutical Co.,Ltd. Details
2.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
2.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.10 Chengdu Kanghong Pharmaceutical Group
2.10.1 Chengdu Kanghong Pharmaceutical Group Details
2.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
2.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPHTHALMIC BIOLOGICS BY MANUFACTURER
3.1 Global Ophthalmic Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Ophthalmic Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Ophthalmic Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Ophthalmic Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Ophthalmic Biologics Manufacturer Market Share in 2023
3.5 Ophthalmic Biologics Market: Overall Company Footprint Analysis
3.5.1 Ophthalmic Biologics Market: Region Footprint
3.5.2 Ophthalmic Biologics Market: Company Product Type Footprint
3.5.3 Ophthalmic Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Ophthalmic Biologics Market Size by Region
4.1.1 Global Ophthalmic Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Ophthalmic Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Ophthalmic Biologics Average Price by Region (2019-2030)
4.2 North America Ophthalmic Biologics Consumption Value (2019-2030)
4.3 Europe Ophthalmic Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Ophthalmic Biologics Consumption Value (2019-2030)
4.5 South America Ophthalmic Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Ophthalmic Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Ophthalmic Biologics Sales Quantity by Type (2019-2030)
5.2 Global Ophthalmic Biologics Consumption Value by Type (2019-2030)
5.3 Global Ophthalmic Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Ophthalmic Biologics Sales Quantity by Application (2019-2030)
6.2 Global Ophthalmic Biologics Consumption Value by Application (2019-2030)
6.3 Global Ophthalmic Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
7.2 North America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
7.3 North America Ophthalmic Biologics Market Size by Country
7.3.1 North America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Ophthalmic Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Ophthalmic Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Ophthalmic Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Ophthalmic Biologics Market Size by Country
8.3.1 Europe Ophthalmic Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Ophthalmic Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Ophthalmic Biologics Market Size by Region
9.3.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
10.2 South America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
10.3 South America Ophthalmic Biologics Market Size by Country
10.3.1 South America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Ophthalmic Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Ophthalmic Biologics Market Size by Country
11.3.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Ophthalmic Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Ophthalmic Biologics Market Drivers
12.2 Ophthalmic Biologics Market Restraints
12.3 Ophthalmic Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Ophthalmic Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ophthalmic Biologics
13.3 Ophthalmic Biologics Production Process
13.4 Ophthalmic Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ophthalmic Biologics Typical Distributors
14.3 Ophthalmic Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Ophthalmic Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ophthalmic Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Ophthalmic Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration Treatment
1.4.3 Diabetic Retinopathy Treatment
1.4.4 Inhibit Abnormal Angiogenesis
1.5 Global Ophthalmic Biologics Market Size & Forecast
1.5.1 Global Ophthalmic Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Ophthalmic Biologics Sales Quantity (2019-2030)
1.5.3 Global Ophthalmic Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Ophthalmic Biologics Product and Services
2.1.4 Sanofi Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Ophthalmic Biologics Product and Services
2.2.4 Novartis Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Ophthalmic Biologics Product and Services
2.3.4 Bayer Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Ophthalmic Biologics Product and Services
2.4.4 Genentech Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
2.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Ophthalmic Biologics Product and Services
2.7.4 Iveric Bio
Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Ophthalmic Biologics Product and Services
2.8.4 Regeneron Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Qilu Pharmaceutical Co.,Ltd.
2.9.1 Qilu Pharmaceutical Co.,Ltd. Details
2.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
2.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.10 Chengdu Kanghong Pharmaceutical Group
2.10.1 Chengdu Kanghong Pharmaceutical Group Details
2.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
2.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPHTHALMIC BIOLOGICS BY MANUFACTURER
3.1 Global Ophthalmic Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Ophthalmic Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Ophthalmic Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Ophthalmic Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Ophthalmic Biologics Manufacturer Market Share in 2023
3.5 Ophthalmic Biologics Market: Overall Company Footprint Analysis
3.5.1 Ophthalmic Biologics Market: Region Footprint
3.5.2 Ophthalmic Biologics Market: Company Product Type Footprint
3.5.3 Ophthalmic Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Ophthalmic Biologics Market Size by Region
4.1.1 Global Ophthalmic Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Ophthalmic Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Ophthalmic Biologics Average Price by Region (2019-2030)
4.2 North America Ophthalmic Biologics Consumption Value (2019-2030)
4.3 Europe Ophthalmic Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Ophthalmic Biologics Consumption Value (2019-2030)
4.5 South America Ophthalmic Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Ophthalmic Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Ophthalmic Biologics Sales Quantity by Type (2019-2030)
5.2 Global Ophthalmic Biologics Consumption Value by Type (2019-2030)
5.3 Global Ophthalmic Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Ophthalmic Biologics Sales Quantity by Application (2019-2030)
6.2 Global Ophthalmic Biologics Consumption Value by Application (2019-2030)
6.3 Global Ophthalmic Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
7.2 North America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
7.3 North America Ophthalmic Biologics Market Size by Country
7.3.1 North America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Ophthalmic Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Ophthalmic Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Ophthalmic Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Ophthalmic Biologics Market Size by Country
8.3.1 Europe Ophthalmic Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Ophthalmic Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Ophthalmic Biologics Market Size by Region
9.3.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
10.2 South America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
10.3 South America Ophthalmic Biologics Market Size by Country
10.3.1 South America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Ophthalmic Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Ophthalmic Biologics Market Size by Country
11.3.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Ophthalmic Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Ophthalmic Biologics Market Drivers
12.2 Ophthalmic Biologics Market Restraints
12.3 Ophthalmic Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Ophthalmic Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ophthalmic Biologics
13.3 Ophthalmic Biologics Production Process
13.4 Ophthalmic Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ophthalmic Biologics Typical Distributors
14.3 Ophthalmic Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Ophthalmic Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Ophthalmic Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Ophthalmic Biologics Product and Services
Table 6. Sanofi Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Ophthalmic Biologics Product and Services
Table 11. Novartis Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Ophthalmic Biologics Product and Services
Table 16. Bayer Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Ophthalmic Biologics Product and Services
Table 21. Genentech Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
Table 31. Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Ophthalmic Biologics Product and Services
Table 36. Iveric Bio
Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Ophthalmic Biologics Product and Services
Table 41. Regeneron Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 45. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
Table 46. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 48. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 49. Chengdu Kanghong Pharmaceutical Group Major Business
Table 50. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
Table 51. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 53. Global Ophthalmic Biologics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Ophthalmic Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Ophthalmic Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Ophthalmic Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Ophthalmic Biologics Production Site of Key Manufacturer
Table 58. Ophthalmic Biologics Market: Company Product Type Footprint
Table 59. Ophthalmic Biologics Market: Company Product Application Footprint
Table 60. Ophthalmic Biologics New Market Entrants and Barriers to Market Entry
Table 61. Ophthalmic Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Ophthalmic Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Ophthalmic Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Ophthalmic Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Ophthalmic Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Ophthalmic Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Ophthalmic Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Ophthalmic Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Ophthalmic Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Ophthalmic Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Ophthalmic Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Ophthalmic Biologics Raw Material
Table 121. Key Manufacturers of Ophthalmic Biologics Raw Materials
Table 122. Ophthalmic Biologics Typical Distributors
Table 123. Ophthalmic Biologics Typical Customers
LIST OF FIGURE
s
Figure 1. Ophthalmic Biologics Picture
Figure 2. Global Ophthalmic Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Ophthalmic Biologics Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Ophthalmic Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Ophthalmic Biologics Consumption Value Market Share by Application in 2023
Figure 12. Age-related Macular Degeneration Treatment Examples
Figure 13. Diabetic Retinopathy Treatment Examples
Figure 14. Inhibit Abnormal Angiogenesis Examples
Figure 15. Global Ophthalmic Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Ophthalmic Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Ophthalmic Biologics Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Ophthalmic Biologics Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Ophthalmic Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Ophthalmic Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Ophthalmic Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Ophthalmic Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Ophthalmic Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Ophthalmic Biologics Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Ophthalmic Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Ophthalmic Biologics Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Ophthalmic Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 57. China Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Ophthalmic Biologics Market Drivers
Figure 78. Ophthalmic Biologics Market Restraints
Figure 79. Ophthalmic Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Ophthalmic Biologics in 2023
Figure 82. Manufacturing Process Analysis of Ophthalmic Biologics
Figure 83. Ophthalmic Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Table 1. Global Ophthalmic Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Ophthalmic Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Ophthalmic Biologics Product and Services
Table 6. Sanofi Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Ophthalmic Biologics Product and Services
Table 11. Novartis Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Ophthalmic Biologics Product and Services
Table 16. Bayer Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Ophthalmic Biologics Product and Services
Table 21. Genentech Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
Table 31. Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Ophthalmic Biologics Product and Services
Table 36. Iveric Bio
Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Ophthalmic Biologics Product and Services
Table 41. Regeneron Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 45. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
Table 46. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 48. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 49. Chengdu Kanghong Pharmaceutical Group Major Business
Table 50. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
Table 51. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 53. Global Ophthalmic Biologics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Ophthalmic Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Ophthalmic Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Ophthalmic Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Ophthalmic Biologics Production Site of Key Manufacturer
Table 58. Ophthalmic Biologics Market: Company Product Type Footprint
Table 59. Ophthalmic Biologics Market: Company Product Application Footprint
Table 60. Ophthalmic Biologics New Market Entrants and Barriers to Market Entry
Table 61. Ophthalmic Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Ophthalmic Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Ophthalmic Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Ophthalmic Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Ophthalmic Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Ophthalmic Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Ophthalmic Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Ophthalmic Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Ophthalmic Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Ophthalmic Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Ophthalmic Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Ophthalmic Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Ophthalmic Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Ophthalmic Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Ophthalmic Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Ophthalmic Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Ophthalmic Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Ophthalmic Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Ophthalmic Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Ophthalmic Biologics Raw Material
Table 121. Key Manufacturers of Ophthalmic Biologics Raw Materials
Table 122. Ophthalmic Biologics Typical Distributors
Table 123. Ophthalmic Biologics Typical Customers
LIST OF FIGURE
s
Figure 1. Ophthalmic Biologics Picture
Figure 2. Global Ophthalmic Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Ophthalmic Biologics Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Ophthalmic Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Ophthalmic Biologics Consumption Value Market Share by Application in 2023
Figure 12. Age-related Macular Degeneration Treatment Examples
Figure 13. Diabetic Retinopathy Treatment Examples
Figure 14. Inhibit Abnormal Angiogenesis Examples
Figure 15. Global Ophthalmic Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Ophthalmic Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Ophthalmic Biologics Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Ophthalmic Biologics Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Ophthalmic Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Ophthalmic Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Ophthalmic Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Ophthalmic Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Ophthalmic Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Ophthalmic Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Ophthalmic Biologics Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Ophthalmic Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Ophthalmic Biologics Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Ophthalmic Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 57. China Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Ophthalmic Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Ophthalmic Biologics Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Ophthalmic Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Ophthalmic Biologics Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Ophthalmic Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Ophthalmic Biologics Market Drivers
Figure 78. Ophthalmic Biologics Market Restraints
Figure 79. Ophthalmic Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Ophthalmic Biologics in 2023
Figure 82. Manufacturing Process Analysis of Ophthalmic Biologics
Figure 83. Ophthalmic Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
